Channa R Jayasekera, MD
Gastroenterology · Scottsdale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Mayo Clinic Arizona · 1,618 clinicians in this group
Looking this up.
Hospitals listed: Mayo Clinic Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jayasekera’s office at (480) 301-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A113689 · Current
Licensed to practise in California · since 2010 · expires 2028-06-30 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mayo Clinic HospitalPhoenix, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Mayo Clinic Health System, which runs 26 hospitals in 5 statesHome of Mayo Clinic Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 5 of 5 · 93% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — SSI - Colon Surgery: 1.616, Oct 2024 – Sep 2025Better than the national rate — Abdominopelvic accidental puncture or laceration rate: 0.36 (0 to 0.99) · 5,539 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 115.44 (80.81 to 150.07) · 306 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.58) · 16,145 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.486, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.56, Oct 2024 – Sep 2025
See every measure and the patient survey for Mayo Clinic Hospital
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 4 better, 7 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 1.616 | Worse | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.36 (0 to 0.99) · 5,539 cases | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 115.44 (80.81 to 150.07) · 306 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.58) · 16,145 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.486 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.75 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 144 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.3 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 884 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.2 · 1,245 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 274 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 5,311 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 17,299 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.04 to 0.35) · 19,712 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.86 to 5.38) · 6,130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.24 (1.25 to 3.22) · 3,321 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.17 (2.23 to 4.11) · 5,145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.11 (6.21 to 12) · 3,094 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.66 (3.86 to 7.47) · 3,309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.68 to 3.02) · 2,189 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.9 · 107 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.682 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.477 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.73 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 228 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 776 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3.8 · 280 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.9 · 1,023 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9 · 1,336 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,118 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.5 to 8.8) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (7.2 to 12.7) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 112 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.2 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 17.8 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.7 (12.7 to 19.3) · 2,211 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.9 to 1.2) · 3,441 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,947 patients answered, 35% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 88% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 86% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 91% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 84% |
| Nurses "always" listened carefully | 86% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 70% |
| "YES", patients would definitely recommend the hospital | 93% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$38,001
Medicare paid this office $38,001 for 311 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,254 | $91 |
| Return visit (30+ min) | 47 | $6,688 | $97 |
| Biopsy of large bowel using a flexible endoscope | 31 | $3,307 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,733 | $195 |
| New patient visit (45+ min) | 35 | $2,541 | $73 |
See all 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,254 | $91 |
| Return visit (30+ min) | 47 | $6,688 | $97 |
| Biopsy of large bowel using a flexible endoscope | 31 | $3,307 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,733 | $195 |
| New patient visit (45+ min) | 35 | $2,541 | $73 |
| Long return visit (40+ min) | 18 | $2,415 | $134 |
| Return visit (30+ min) | 32 | $2,305 | $64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,314 | $69 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,139 | $63 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,043 | $70 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $864 | $72 |
| Measurement of liver stiffness | 78 | $530 | $7 |
Procedures Medicare counted
| Colonoscopy | 24 | More than 50% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 22 | More than 52% of doctors who do this |
Who their Medicare patients are
311 Original Medicare patients in 2024. Average age 71 · Under 65 10% · 85 and older 5% · Women 48% · Also on Medicaid 6% · Health risk score 2.44. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 73% · Chronic kidney disease 49% · Diabetes 41% · Coronary heart disease 27% · Depression 27% · Atrial fibrillation 21% · Heart failure 20% · Cancer 17% · COPD 11% · Dementia 9% · Stroke 8%.
The office billed $273,157, Medicare allowed $50,020 and paid $38,001; for 506 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 311 | 506 | 71 | 2.44 | $273,157 | $38,001 |
| 2023 | 254 | 412 | 71 | 2.68 | $226,341 | $32,135 |
| 2022 | 308 | 558 | 69 | 2.46 | $198,171 | $38,156 |
| 2021 | 210 | 345 | 70 | 2.33 | $50,692 | $28,067 |
| 2020 | 15 | 31 | 65 | 1.61 | $5,512 | $1,197 |
| 2019 | 21 | 179 | 68 | 2.26 | $16,596 | $3,447 |
| 2018 | 25 | 81 | 67 | 2.48 | $25,190 | $6,951 |
| 2017 | 108 | 267 | 66 | 3.05 | $125,274 | $26,062 |
| 2016 | 55 | 99 | 68 | 2.88 | $53,344 | $10,049 |
| 2015 | 21 | 25 | 74 | 2.98 | $5,802 | $1,718 |
| 2014 | 11 | 12 | 60 | 2.24 | $2,695 | $1,012 |
| 2013 | 34 | 39 | 64 | 2.13 | $11,814 | $3,542 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $7,510 | $92 |
| Return visit (30+ min) | 32 | $3,773 | $92 |
| New patient visit (60+ min) | 23 | $3,058 | $133 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,262 | $206 |
| Long return visit (40+ min) | 14 | $1,926 | $128 |
| Return visit (30+ min) | 18 | $1,793 | $69 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,476 | $82 |
| Biopsy of large bowel using a flexible endoscope | 19 | $1,415 | $74 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,403 | $88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $982 | $76 |
| Long return visit (40+ min) | 11 | $893 | $81 |
| Measurement of liver stiffness | 74 | $491 | $7 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $9,570 | $78 |
| Return visit (30+ min) | 61 | $7,703 | $92 |
| Long return visit (40+ min) | 30 | $4,305 | $130 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,112 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,722 | $157 |
| New patient visit (60+ min) | 14 | $1,713 | $122 |
| Return visit (30+ min) | 16 | $1,372 | $76 |
| Measurement of liver stiffness | 107 | $755 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $565 | $21 |
2021: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,098 | $80 |
| Return visit (30+ min) | 30 | $3,522 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $2,870 | $191 |
| Long return visit (40+ min) | 15 | $2,140 | $143 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,054 | $147 |
| Biopsy of large bowel using a flexible endoscope | 22 | $2,032 | $92 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,022 | $81 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $921 | $77 |
| Measurement of liver stiffness | 46 | $394 | $9 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $74 | $4 |
2018: 1 service
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $417 | $38 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $10,096 | $93 |
| Long return visit (40+ min) | 32 | $4,384 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,983 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,579 | $121 |
| New patient visit (60+ min) | 11 | $1,510 | $137 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $62 | $4 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $870 | $62 |
2013: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,251 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $809 | $62 |
Drugs they prescribed that Part D paid
$276,806
Pharmacies billed $276,806 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (15 of 813) in 2024. A higher opioid share than 9 in 10 peers; the typical gastroenterology clinician is at 0%.
732 generic and 81 brand-name prescriptions · $276,806 in drug cost · 51 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Everolimus | 18 | $70,374 | $3,910 |
| Xifaxan | 18 | $64,347 | $3,575 |
| Eliquis | 21 | $14,062 | $670 |
| Tacrolimus | 123 | $13,179 | $107 |
| Ursodiol | 51 | $5,286 | $104 |
See all 19 drugs
| Everolimus | 18 | $70,374 | $3,910 |
| Xifaxan | 18 | $64,347 | $3,575 |
| Eliquis | 21 | $14,062 | $670 |
| Tacrolimus | 123 | $13,179 | $107 |
| Ursodiol | 51 | $5,286 | $104 |
| Entecavir | 23 | $4,034 | $175 |
| Valganciclovir | 18 | $3,700 | $206 |
| Fluconazole | 100 | $3,236 | $32 |
| Cyclosporine Modified | 13 | $1,810 | $139 |
| Mycophenolate Mofetil | 23 | $1,311 | $57 |
| Dapsone | 12 | $766 | $64 |
| Pantoprazole | 34 | $423 | $12 |
| Prednisone | 25 | $265 | $11 |
| Spironolactone | 13 | $247 | $19 |
| Sulfamethoxazole-Trimethoprim | 25 | $130 | $5 |
| Methocarbamol | 19 | $122 | $6 |
| Carvedilol | 19 | $88 | $5 |
| Warfarin | 11 | $79 | $7 |
| Furosemide | 20 | $53 | $3 |
Year by year
| 2024 | 813 | 265 | 2% (15) | 10% | $276,806 |
| 2023 | 739 | 257 | 2% (14) | None | $149,145 |
| 2022 | 656 | 195 | 2% (11) | None | $62,270 |
| 2021 | 441 | 156 | None | 20% | $158,134 |
| 2020 | 366 | 87 | 0% (0) | 31% | $412,280 |
| 2019 | 317 | 76 | 0% (0) | 35% | $294,969 |
| 2018 | 187 | 67 | 0% (0) | 40% | $222,912 |
| 2017 | 107 | 46 | 0% (0) | 30% | $157,972 |
| 2016 | 20 | 12 | 0% (0) | None | $2,218 |
| 2015 | 27 | None | 0% (0) | None | $1,944 |
| 2014 | 17 | None | 0% (0) | None | $3,989 |
| 2013 | 29 | 15 | 0% (0) | 48% | $8,938 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Xifaxan | 14 | $66,999 | $4,786 |
| Tacrolimus | 133 | $18,722 | $141 |
| Mycophenolate Mofetil | 45 | $4,579 | $102 |
| Valganciclovir | 14 | $4,353 | $311 |
| Fluconazole | 103 | $4,018 | $39 |
| Lactulose | 24 | $1,585 | $66 |
| Ursodiol | 16 | $1,449 | $91 |
| Amantadine | 12 | $1,264 | $105 |
| Pantoprazole | 28 | $408 | $15 |
| Spironolactone | 16 | $397 | $25 |
| Prednisone | 22 | $232 | $11 |
| Sulfamethoxazole-Trimethoprim | 21 | $170 | $8 |
| Amlodipine Besylate | 13 | $93 | $7 |
| Methocarbamol | 12 | $68 | $6 |
| Furosemide | 18 | $59 | $3 |
2022: 15 drugs
| Tacrolimus | 122 | $14,376 | $118 |
| Valganciclovir | 18 | $6,481 | $360 |
| Fluconazole | 89 | $5,457 | $61 |
| Ursodiol | 25 | $4,540 | $182 |
| Mycophenolate Mofetil | 30 | $2,567 | $86 |
| Entecavir | 12 | $1,336 | $111 |
| Lactulose | 20 | $949 | $47 |
| Pantoprazole | 21 | $338 | $16 |
| Sulfamethoxazole-Trimethoprim | 39 | $329 | $8 |
| Omeprazole | 15 | $204 | $14 |
| Prednisone | 19 | $201 | $11 |
| Rosuvastatin | 11 | $180 | $16 |
| Acyclovir | 14 | $179 | $13 |
| Furosemide | 27 | $87 | $3 |
| Amlodipine Besylate | 17 | $77 | $5 |
2021: 11 drugs
| Xifaxan | 21 | $52,264 | $2,489 |
| Vemlidy | 21 | $27,867 | $1,327 |
| Tacrolimus | 49 | $5,777 | $118 |
| Ursodiol | 15 | $4,953 | $330 |
| Lactulose | 12 | $1,323 | $110 |
| Fluconazole | 15 | $1,242 | $83 |
| Entecavir | 11 | $993 | $90 |
| Spironolactone | 26 | $759 | $29 |
| Omeprazole | 28 | $369 | $13 |
| Furosemide | 34 | $328 | $10 |
| Prednisone | 16 | $294 | $18 |
2020: 12 drugs
| Humira | 11 | $45,671 | $4,152 |
| Xifaxan | 16 | $35,393 | $2,212 |
| Vemlidy | 20 | $30,957 | $1,548 |
| Ursodiol | 19 | $3,398 | $179 |
| Lactulose | 11 | $2,159 | $196 |
| Entecavir | 12 | $1,434 | $119 |
| Spironolactone | 30 | $957 | $32 |
| Tacrolimus | 25 | $829 | $33 |
| Diltiazem | 14 | $377 | $27 |
| Prednisone | 17 | $351 | $21 |
| Omeprazole | 22 | $349 | $16 |
| Furosemide | 24 | $267 | $11 |
2019: 8 drugs
| Epclusa | 18 | $154,597 | $8,589 |
| Ursodiol | 18 | $2,364 | $131 |
| Lactulose | 15 | $1,470 | $98 |
| Spironolactone | 42 | $1,251 | $30 |
| Peg 3350-Electrolyte | 17 | $602 | $35 |
| Tacrolimus | 13 | $533 | $41 |
| Furosemide | 37 | $346 | $9 |
| Omeprazole | 20 | $337 | $17 |
2018: 5 drugs
| Lactulose | 17 | $532 | $31 |
| Tacrolimus | 13 | $479 | $37 |
| Spironolactone | 19 | $446 | $23 |
| Peg 3350-Electrolyte | 33 | $390 | $12 |
| Furosemide | 15 | $55 | $4 |
2017: 1 drug
| Spironolactone | 12 | $164 | $14 |
Money from drug and device companies
$239 in 2025
A payment is not proof that care is biased.
| Sequana Medical US | Alfapump System | $220 | 2 payments
|
| Astellas Pharma US | Cresemba | $19 | 1 payment
|
See all 3 published payments
| Sequana Medical US | Meals · 2025-12-01 | Alfapump System | $21 |
| Sequana Medical US | Meals · 2025-09-25 | Alfapump System | $199 |
| Astellas Pharma US | Meals · 2025-04-15 | Cresemba | $19 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 78.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1790095040
- Licence
- AZ 63158, CA A113689California A113689: Current · expires 2028-06-30
- Group
- Mayo Clinic Arizona
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 13400 E Shea Blvd, Scottsdale, AZ, 85259
- NPI first listed
- 2010-10-19
- NPI last updated
- 2021-04-19
- NPI record certified
- 2021-04-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 750 Welch Rd, Palo Alto, CA, 94304
This office lists an electronic records connection.